A new study shows a steroid, dexamethasone, improves the survival of some COVID-19 patients, especially those with severe forms of the diseases. These include some on ventilators and some who require ...
Medical workers attend to a COVID-19 patient in an intensive care unit at a hospital in Sana, Yemen. (Hani Mohammed / Associated Press) In a development that could dramatically shrink the death toll ...
A full study testing dexamethasone — a cheap, widely available steroid — as a treatment for COVID-19 found that the drug reduced mortality rates among patients on ventilators or who were receiving ...
A British trial showing that a common steroid could reduce deaths in severe COVID-19 cases by one-third was good news for Minnesota physicians who have been battling the infectious disease without a ...
Dexamethasone may help save up to one-third of patients on ventilators. As the world awaits a COVID-19 vaccine, researchers studying possible treatments have found a commonly used steroid called ...
The IMiD lenalidomide has shown promising results as a single agent 16 as well as in combination with other active agents for the treatment of MM. 15, 17, 18, 19, 20 ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio LISBON, Portugal — After a comprehensive ...
A dexamethasone-sparing regimen involving lenalidomide (Revlimid) and the anti-CD38 drug daratumumab (Darzalex) was safe and effective in older, frail patients with newly diagnosed multiple myeloma, ...
A dexamethasone-sparing regimen of daratumumab and lenalidomide was safe and effective in older, frail patients with newly diagnosed multiple myeloma. Among that select group of patients, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback